See What HealthDay Can Do For You
Contact Us

Senators Urge Biden to Waive Rules That Restrict COVID-19 Vaccine Production

Waiver could open the door for generic or other manufacturers to make more vaccines

glass bottles of vaccine liquid with pink and blue caps

FRIDAY, April 16, 2021 (HealthDay News) -- The United States should support efforts to temporarily waive intellectual property rules so that nations struggling to vaccinate their populations against COVID-19 can get more vaccines, 10 senators urged in a letter to President Joe Biden.

They wrote that the White House should "prioritize people over pharmaceutical company profits" and that a waiver could open the door for generic or other manufacturers to make more vaccines, the Associated Press reported.

India and South Africa have appealed to the World Health Organization for such a waiver, which is supported by more than 100 nations. "Simply put, we must make vaccines, testing, and treatments accessible everywhere if we are going to crush the virus anywhere," the lawmakers say in the letter, the AP reported.

Drug companies and other opponents claim such a waiver would set a dangerous precedent in allowing scientists worldwide to copy American and European companies' research.

The Biden administration has said it is studying the matter and did not respond to the AP's request for comment on the senators' letter.

Associated Press Article

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.